Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Department of Ophthalmology and Visual Sciences, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Facial Plast Surg Aesthet Med. 2023 Mar-Apr;25(2):103-107. doi: 10.1089/fpsam.2021.0276. Epub 2021 Dec 21.
The Michigan Opioid Laws are legislation enacted between 2017 and 2018 as a strategy to combat the growing opioid crisis. To compare opioid prescription rates and morphine milligram equivalents (MMEs) of opioid prescribed to patients undergoing various facial plastic and reconstructive surgery (FPRS) procedures before, during, and after legislation enactment. This is a cross-sectional retrospective review of subjects undergoing any of 10 FPRS procedures between July 2016 and November 2019 at a tertiary care hospital with analysis of demographic factors, opioid prescription rates, and MMEs over time. Of 863 patients included, 107 and 575 patients were prescribed postoperative opioids before and after opiate legislation enactment, respectively, with no difference in baseline demographics between groups. Regression analysis showed no change in MME prescribing in the year before legislation ( = 0.70), followed by a decrease of 0.13 MME per day ( = 0.00), with a subsequent stabilization of MME at a reduced rate for the remainder of the study period ( = 0.74). Enactment of the Michigan Opioid Laws was temporally associated with a decrease in opioid prescriptions for common facial plastic surgery procedures.
密歇根州阿片类药物法是 2017 年至 2018 年期间颁布的一项法规，旨在应对日益严重的阿片类药物危机。本研究旨在比较立法前后患者接受各种面部整形和重建手术（FPRS）前后的阿片类药物处方率和吗啡毫克当量（MME）。这是一项回顾性的横断面研究，分析了 2016 年 7 月至 2019 年 11 月在一家三级护理医院接受 10 种 FPRS 手术的受试者的人口统计学因素、阿片类药物处方率和 MME 随时间的变化。在 863 名患者中，有 107 名和 575 名患者分别在阿片类药物立法前后开了术后阿片类药物，两组之间的基线人口统计学特征无差异。回归分析显示，在立法前一年 MME 处方量没有变化（ = 0.70），随后每天减少 0.13 MME（ = 0.00），在研究期间的剩余时间里，MME 以较低的速度稳定下来（ = 0.74）。密歇根州阿片类药物法的颁布与常见面部整形手术中阿片类药物处方的减少呈时间相关。
